Last Close
60.35 $
Jul 7, 26
Market Cap
11.9 B $
Q1 2026 (TTM)
52-Week Range
%+5.1
%34.9
-0.83
-1.02
%-5.8
-%22.5
1M
+6.3%
3M
+7.3%
6M
+0.5%
YTD
+1.5%
1Y
+5.1%
3Y
-29.1%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
BMRN last closed at 60.35 $ (Jul 7, 26). Price data is refreshed after every trading day.
Biomarin Pharmaceutical Inc trades at a trailing-twelve-month P/E of 44.39. See the comparison tables on the Peers tab for the industry context.
Biomarin Pharmaceutical Inc (BMRN) has a market capitalization of approximately 11.9 B $ as of the latest reported period.
Key peers of Biomarin Pharmaceutical Inc include CSL Ltd, TELIX Pharmaceuticals Ltd, Mesoblast Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.